MedPath

A Pilot Study - Comparison of Two Hologic 3D Mammography Systems

Completed
Conditions
Breast Cancer
Interventions
Device: Genesis and Gemini
Device: Investigational 3D Mammography system
Registration Number
NCT00759447
Lead Sponsor
Hologic, Inc.
Brief Summary

Study to compare the prototype tomosynthesis mammography system to the tomosynthesis system slated for commercial release.

Detailed Description

A perspective non randomized, noncontrolled, multicenter pilot study enrolling a minimum of 60 female subjects. The purpose of the pilot study is to compare the images acquired from two Hologic tomosynthesis systems. Information obtained from the study will be used to determine endpoints for a future larger study. Study participants are enrolled in one of three groups, the group in which they are enrolled wil determine which tomosynthesis system images will be acquired upon.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
240
Inclusion Criteria
  • Female, any ethnic origin
  • No contraindication for diagnostic mammography
Exclusion Criteria
  • Any contraindications to mammographic imaging including but not limited to significant existing breast trauma, pregnancy, lactating, breast implants.
  • Under 30 years of age at the time of consent
  • Unable to understand and execute written informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
3D Imaging with commercial Mammography DeviceGenesis and Gemini-
3D investigational imagingInvestigational 3D Mammography systemPatients enrolled will be imaged with a 3D mammogram in one of 3 speeds of acquisition
Primary Outcome Measures
NameTimeMethod
Pilot study- To Evaluate the images acquired on 2 prototype systems for a larger study design1 year

images are acquired on 2 systems with different speeds of time and reviewed compared to 2D images. Subjects are enrolled in one group or another and are diagnostic patients returning for addition work up on an area of interest

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath